Literature DB >> 24561146

Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Melanie D Everitt1, Lynn A Sleeper2, Minmin Lu2, Charles E Canter3, Elfriede Pahl4, James D Wilkinson5, Linda J Addonizio6, Jeffrey A Towbin7, Joseph Rossano8, Rakesh K Singh9, Jacqueline Lamour9, Steven A Webber10, Steven D Colan11, Renee Margossian11, Paul F Kantor12, John L Jefferies9, Steven E Lipshultz6.   

Abstract

OBJECTIVES: This study sought to determine the incidence and predictors of recovery of normal echocardiographic function among children with idiopathic dilated cardiomyopathy (DCM).
BACKGROUND: Most children with idiopathic DCM have poor outcomes; however, some improve.
METHODS: We studied children <18 years of age from the Pediatric Cardiomyopathy Registry who had both depressed left ventricular (LV) function (fractional shortening or ejection fraction z-score <-2) and LV dilation (end-diastolic dimension [LVEDD] z-score >2) at diagnosis and who had at least 1 follow-up echocardiogram 30 days to 2 years from the initial echocardiogram. We estimated the cumulative incidence and predictors of normalization.
RESULTS: Among 868 children who met the inclusion criteria, 741 (85%) had both echocardiograms. At 2 years, 22% had recovered normal LV function and size; 51% had died or undergone heart transplantation (median, 3.2 months), and 27% had persistently abnormal echocardiograms. Younger age (hazard ratio [HR]: 0.92; 95% confidence interval [CI]: 0.88 to 0.97) and lower LVEDD z-score (HR: 0.78; 95% CI: 0.70 to 0.87) independently predicted normalization. Nine children (9%) with normal LV function and size within 2 years of diagnosis later underwent heart transplantation or died.
CONCLUSIONS: Despite marked LV dilation and depressed function initially, children with idiopathic DCM can recover normal LV size and function, particularly those younger and with less LV dilation at diagnosis. Investigations related to predictors of recovery, such as genetic associations, serum markers, and the impact of medical therapy or ventricular unloading with assist devices are important next steps. Longer follow-up after normalization is warranted as cardiac failure can recur. (Pediatric Cardiomyopathy Registry; NCT00005391).
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiomyopathy; echocardiography; heart failure; pediatrics

Mesh:

Year:  2014        PMID: 24561146      PMCID: PMC4030008          DOI: 10.1016/j.jacc.2013.11.059

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  Theoretical and empirical derivation of cardiovascular allometric relationships in children.

Authors:  Thierry Sluysmans; Steven D Colan
Journal:  J Appl Physiol (1985)       Date:  2004-11-19

2.  Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study.

Authors:  Piers E F Daubeney; Alan W Nugent; Patty Chondros; John B Carlin; Steven D Colan; Michael Cheung; Andrew M Davis; C W Chow; Robert G Weintraub
Journal:  Circulation       Date:  2006-11-20       Impact factor: 29.690

3.  Outcome factors of idiopathic dilated cardiomyopathy in children - a long-term follow-up review.

Authors:  Vitor Manuel P Azevedo; Marco Aurelio Santos; Francisco M Albanesi Filho; Márcia B Castier; Bernardo R Tura; Jose Geraldo C Amino
Journal:  Cardiol Young       Date:  2007-01-23       Impact factor: 1.093

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry.

Authors:  Susan R Foerster; Charles E Canter; Amy Cinar; Lynn A Sleeper; Steven A Webber; Elfriede Pahl; Paul F Kantor; Jorge A Alvarez; Steven D Colan; John L Jefferies; Jacqueline M Lamour; Renee Margossian; Jane E Messere; Paolo G Rusconi; Robert E Shaddy; Jeffrey A Towbin; James D Wilkinson; Steven E Lipshultz
Journal:  Circ Heart Fail       Date:  2010-09-10       Impact factor: 8.790

6.  Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Authors:  Jorge A Alvarez; E John Orav; James D Wilkinson; Lora E Fleming; David J Lee; Lynn A Sleeper; Paolo G Rusconi; Steven D Colan; Daphne T Hsu; Charles E Canter; Steven A Webber; Gerald F Cox; John L Jefferies; Jeffrey A Towbin; Steven E Lipshultz
Journal:  Circulation       Date:  2011-07-25       Impact factor: 29.690

7.  Left ventricular reverse remodeling in long-term (>12 years) survivors with idiopathic dilated cardiomyopathy.

Authors:  Yoshihisa Matsumura; Eri Hoshikawa-Nagai; Toru Kubo; Naohito Yamasaki; Takashi Furuno; Hiroaki Kitaoka; Jun Takata; Tetsuro Sugiura; Yoshinori Doi
Journal:  Am J Cardiol       Date:  2012-10-02       Impact factor: 2.778

8.  Recovery of heart function in children with acute severe heart failure.

Authors:  John J O'Sullivan; Susan L Roche; David S Crossland; Milind P Chaudhari; Richard C Kirk; Hasan Asif
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

9.  Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.

Authors:  Tajinder P Singh; Lynn A Sleeper; Steven Lipshultz; Amy Cinar; Charles Canter; Steven A Webber; Daniel Bernstein; Elfriede Pahl; Jorge A Alvarez; James D Wilkinson; Jeffrey A Towbin; Steven D Colan
Journal:  Circ Heart Fail       Date:  2009-09-28       Impact factor: 8.790

10.  Carvedilol for children and adolescents with heart failure: a randomized controlled trial.

Authors:  Robert E Shaddy; Mark M Boucek; Daphne T Hsu; Robert J Boucek; Charles E Canter; Lynn Mahony; Robert D Ross; Elfriede Pahl; Elizabeth D Blume; Debra A Dodd; David N Rosenthal; Jeri Burr; Bernie LaSalle; Richard Holubkov; Mary Ann Lukas; Lloyd Y Tani
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

View more
  29 in total

1.  Identifying Non-invasive Tools to Distinguish Acute Myocarditis from Dilated Cardiomyopathy in Children.

Authors:  Divya Suthar; Debra A Dodd; Justin Godown
Journal:  Pediatr Cardiol       Date:  2018-04-12       Impact factor: 1.655

2.  Prognostic significance of tissue Doppler imaging-derived myocardial performance index in pediatric patients with dilated cardiomyopathy.

Authors:  Lydia K Wright; Falon McGaughy; Michael Kellerman; William L Border; Ritu Sachdeva
Journal:  Pediatr Transplant       Date:  2019-11-10

Review 3.  Pediatric Cardiomyopathies.

Authors:  Teresa M Lee; Daphne T Hsu; Paul Kantor; Jeffrey A Towbin; Stephanie M Ware; Steven D Colan; Wendy K Chung; John L Jefferies; Joseph W Rossano; Chesney D Castleberry; Linda J Addonizio; Ashwin K Lal; Jacqueline M Lamour; Erin M Miller; Philip T Thrush; Jason D Czachor; Hiedy Razoky; Ashley Hill; Steven E Lipshultz
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy.

Authors:  Rakesh K Singh; Charles E Canter; Ling Shi; Steven D Colan; Debra A Dodd; Melanie D Everitt; Daphne T Hsu; John L Jefferies; Paul F Kantor; Elfriede Pahl; Joseph W Rossano; Jeffrey A Towbin; James D Wilkinson; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2017-11-28       Impact factor: 24.094

5.  The relationship between electrocardiographic data and mortality in children diagnosed with dilated cardiomyopathy.

Authors:  Mehmet Türe; Hasan Balık; Alper Akın; Meki Bilici; Ahmet Nergiz
Journal:  Eur J Pediatr       Date:  2020-01-14       Impact factor: 3.183

6.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20

Review 7.  From pediatrics to geriatrics: Mechanisms of heart failure across the life-course.

Authors:  Kathleen C Woulfe; Danielle R Bruns
Journal:  J Mol Cell Cardiol       Date:  2018-11-17       Impact factor: 5.000

8.  Anaesthetic management of laparoscopic surgery for rectal cancer in patients of dilated cardiomyopathy with poor ejection fraction: a case report.

Authors:  Yao-Hua Wu; Liang Hu; Jin Xia; Quan-Shui Hao; Li Feng; Hong-Bing Xiang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry.

Authors:  Melanie D Everitt; James D Wilkinson; Ling Shi; Jeffrey A Towbin; Steven D Colan; Paul F Kantor; Charles E Canter; Steven A Webber; Daphne T Hsu; Elfriede Pahl; Linda J Addonizio; Debra A Dodd; John L Jefferies; Joseph W Rossano; Brian Feingold; Stephanie M Ware; Teresa M Lee; Justin Godown; Kathleen E Simpson; Lynn A Sleeper; Jason D Czachor; Hiedy Razoky; Ashley Hill; Joslyn Westphal; Kimberly M Molina; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2019-03-07

Review 10.  Beyond genomics-technological advances improving the molecular characterization and precision treatment of heart failure.

Authors:  Kory J Lavine; Michael J Greenberg
Journal:  Heart Fail Rev       Date:  2020-09-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.